Discutirla en las sesiones de Educación Médica Continuada del hospital.
" When our analysis limited to the studies only included patient with antihypertensive indication, a significant lower risk of mortality was observed among those with ACEI/ARB use (OR = 0.62, 95%CI 0.38-1.02, P = 0.059; Fig. 3).
After excluded studies enrolled patients with hypertension but without antihypertensive treatment, the meta-analysis of four studies also found that ACEI/ARB exposure was associated with a lower risk of mortality compared those with non-ACEI/ARB antihypertensive drugs (OR = 0.48, 95% CI 0.29-0.81, P = 0.006; I2 = 0%) ".
Desde Nicaragua
Clínica de Asma y Alergia
Dr. Juan Herrera Salazar
Whatsapp 88825513, 84316459.
Whatsapp 88825513, 84316459.
No hay comentarios:
Publicar un comentario